TAS2R41

gene
On this page

Also known as T2R59

Summary

TAS2R41 (taste 2 receptor member 41, HGNC:18883) is a protein-coding gene on chromosome 7q35, encoding Taste receptor type 2 member 41 (P59536). Receptor that may play a role in the perception of bitterness and is gustducin-linked.

This gene encodes a member of the bitter taste receptor family which belong to the G protein-coupled receptor superfamily and are predominantly expressed in taste receptor cells of the tongue and palate epithelia. This intronless taste receptor gene encodes a seven-transmembrane receptor protein, functioning as a bitter taste receptor. This gene is clustered together with eight other taste receptor genes on chromosome 7. Chloramphenicol is an agonist for the encoded protein.

Source: NCBI Gene 259287 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 1 total
  • Druggable target: yes — 1 molecules with ChEMBL bioactivity
  • MANE Select transcript: NM_176883

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18883
Approved symbolTAS2R41
Nametaste 2 receptor member 41
Location7q35
Locus typegene with protein product
StatusApproved
AliasesT2R59
Ensembl geneENSG00000221855
Ensembl biotypeprotein_coding
OMIM613965
Entrez259287

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000408916

RefSeq mRNA: 1 — MANE Select: NM_176883 NM_176883

CCDS: CCDS43663

Canonical transcript exons

ENST00000408916 — 1 exons

ExonStartEnd
ENSE00001574645143477873143478796

Expression profiles

Bgee: expression breadth tissue_specific, 1 present calls, max score 49.69.

Top tissues by expression

124 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
bone marrow cellCL:000209249.69gold quality
granulocyteCL:000009441.03gold quality
bone marrowUBERON:000237140.26gold quality
colonic epitheliumUBERON:000039737.20gold quality
mucosa of stomachUBERON:000119936.84silver quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
hindlimb stylopod muscleUBERON:000425236.29silver quality
ganglionic eminenceUBERON:000402335.49gold quality
tonsilUBERON:000237234.97gold quality
skeletal muscle tissueUBERON:000113434.96gold quality
muscle tissueUBERON:000238532.22gold quality
lymph nodeUBERON:000002930.77silver quality
urinary bladderUBERON:000125530.35gold quality
liverUBERON:000210729.92gold quality
stromal cell of endometriumCL:000225529.87gold quality
prefrontal cortexUBERON:000045129.04gold quality
leukocyteCL:000073828.52gold quality
duodenumUBERON:000211428.14gold quality
calcaneal tendonUBERON:000370127.88gold quality
primary visual cortexUBERON:000243627.84gold quality
monocyteCL:000057627.83gold quality
vermiform appendixUBERON:000115426.42gold quality
gall bladderUBERON:000211025.98gold quality
olfactory segment of nasal mucosaUBERON:000538625.89gold quality
placentaUBERON:000198725.81gold quality
uterine cervixUBERON:000000225.35gold quality
descending thoracic aortaUBERON:000234524.58gold quality
kidneyUBERON:000211324.34gold quality
tibial arteryUBERON:000761024.30gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriotas2r200.2ENSDARG00000074066
danio_reriotas2r200.1ENSDARG00000079880
mus_musculusTas2r126ENSMUSG00000048284
rattus_norvegicusTas2r126ENSRNOG00000017881

Paralogs (23): TAS2R8 (ENSG00000121314), TAS2R10 (ENSG00000121318), TAS2R7 (ENSG00000121377), TAS2R9 (ENSG00000121381), TAS2R3 (ENSG00000127362), TAS2R4 (ENSG00000127364), TAS2R5 (ENSG00000127366), TAS2R16 (ENSG00000128519), TAS2R1 (ENSG00000169777), TAS2R60 (ENSG00000185899), TAS2R42 (ENSG00000186136), TAS2R19 (ENSG00000212124), TAS2R50 (ENSG00000212126), TAS2R14 (ENSG00000212127), TAS2R13 (ENSG00000212128), TAS2R40 (ENSG00000221937), TAS2R46 (ENSG00000226761), TAS2R39 (ENSG00000236398), TAS2R43 (ENSG00000255374), TAS2R20 (ENSG00000255837), TAS2R30 (ENSG00000256188), TAS2R31 (ENSG00000256436), TAS2R38 (ENSG00000257138)

Protein

Protein identifiers

Taste receptor type 2 member 41P59536 (reviewed: P59536)

Alternative names: Taste receptor type 2 member 59

All UniProt accessions (1): P59536

UniProt curated annotations — full annotation on UniProt →

Function. Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5.

Subcellular location. Membrane.

Tissue specificity. Expressed in subsets of taste receptor cells of the tongue and exclusively in gustducin-positive cells.

Miscellaneous. Most taste cells may be activated by a limited number of bitter compounds; individual taste cells can discriminate among bitter stimuli.

Similarity. Belongs to the G-protein coupled receptor T2R family.

RefSeq proteins (1): NP_795364* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR007960TAS2RFamily

Pfam: PF05296

UniProt features (19 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P59536-F184.980.51

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (1): 167

Function

Pathways and Gene Ontology

Reactome pathways

9 pathways

IDPathway
R-HSA-418594G alpha (i) signalling events
R-HSA-420499Class C/3 (Metabotropic glutamate/pheromone receptors)
R-HSA-9717207Sensory perception of sweet, bitter, and umami (glutamate) taste
R-HSA-162582Signal Transduction
R-HSA-372790Signaling by GPCR
R-HSA-388396GPCR downstream signalling
R-HSA-500792GPCR ligand binding
R-HSA-9709957Sensory Perception
R-HSA-9717189Sensory perception of taste

MSigDB gene sets: 28 (showing top): GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE, GOBP_SENSORY_PERCEPTION_OF_TASTE, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr7q35, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY, GOMF_TASTE_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, GOBP_SENSORY_PERCEPTION_OF_BITTER_TASTE, TTANTCA_UNKNOWN, REACTOME_SENSORY_PERCEPTION

GO Biological Process (3): sensory perception of taste (GO:0050909), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186)

GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), protein binding (GO:0005515), bitter taste receptor activity (GO:0033038)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-6 pathways:

CategoryPathways
Signaling by GPCR2
GPCR downstream signalling1
GPCR ligand binding1
Sensory perception of taste1
Signal Transduction1
Sensory Perception1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
sensory perception of chemical stimulus1
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
G protein-coupled receptor activity1
signal transduction1
transmembrane signaling receptor activity1
G protein-coupled receptor signaling pathway1
binding1
detection of chemical stimulus involved in sensory perception of bitter taste1
taste receptor activity1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

358 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TAS2R41TAS1R1Q7RTX1618
TAS2R41TAS1R3Q7RTX0580
TAS2R41TAS1R2Q8TE23568
TAS2R41PKD2L1Q9P0L9560
TAS2R41PKD1L3Q7Z443560
TAS2R41OR5J2Q8NH18501
TAS2R41OR51I2Q9H344477
TAS2R41OR13G1Q8NGZ3448
TAS2R41HCN4Q9Y3Q4410
TAS2R41SCNN1DP51172380
TAS2R41OR12D2P58182370
TAS2R41GPRC6AQ5T6X5369
TAS2R41MYO3AQ8NEV4344
TAS2R41CASRP41180331
TAS2R41VSTM2BA6NLU5321

IntAct

6 interactions, top by confidence:

ABTypeScore
TAS2R41DESI1psi-mi:“MI:0915”(physical association)0.560
TAS2R41YKT6psi-mi:“MI:0914”(association)0.530
TAS2R41DESI1psi-mi:“MI:0915”(physical association)0.000

BioGRID (33): YKT6 (Affinity Capture-MS), PAK1 (Affinity Capture-MS), LASP1 (Affinity Capture-MS), SNX3 (Affinity Capture-MS), NIPSNAP3A (Affinity Capture-MS), SEPHS1 (Affinity Capture-MS), CBFB (Affinity Capture-MS), SCRN2 (Affinity Capture-MS), PAK1 (Affinity Capture-MS), CBFB (Affinity Capture-MS), SNX3 (Affinity Capture-MS), SCRN2 (Affinity Capture-MS), MECR (Affinity Capture-MS), YKT6 (Affinity Capture-MS), CHRAC1 (Affinity Capture-MS)

ESM2 similar proteins: A0A0R4IM31, A0A0R4IP11, P59532, P59533, P59536, P59551, Q2AB83, Q4VHE7, Q5J3F6, Q5J3L4, Q5J3L7, Q5J3M3, Q5J3M9, Q5J3N1, Q5Y4Z0, Q645S2, Q645U0, Q645U6, Q645U7, Q645Y3, Q645Z0, Q645Z1, Q646A4, Q646A5, Q646B2, Q646C7, Q646D0, Q646D5, Q646E6, Q646E9, Q646F3, Q67ER9, Q67ES2, Q67ES7, Q697L2, Q697L3, Q697L4, Q697L5, Q697L6, Q7TQA6

Diamond homologs: P59529, P59536, P59551, Q5Y4Z0, Q645S2, Q645U1, Q645U2, Q645U6, Q645U7, Q645Y3, Q645Y4, Q645Z0, Q646A5, Q646B2, Q646B3, Q646C7, Q646D0, Q646D1, Q646E7, Q646E8, Q646F1, Q646F3, Q646G6, Q67ES2, Q67ES3, Q67ES7, Q7M720, Q7TQA7, Q7TQA9, Q7TQB0, Q7TQB9, Q9JKE7, Q9JKF0, Q9JKT7, Q9JKU0, Q9NYV7, P59530, P59532, P59534, P59537

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

1 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance1
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

248 predictions. Top by Δscore:

VariantEffectΔscore
7:143477918:C:Gdonor_gain0.9000
7:143477971:G:GTdonor_gain0.8600
7:143477989:C:Tdonor_gain0.8600
7:143477993:T:TAdonor_gain0.7100
7:143478621:T:TAacceptor_gain0.6900
7:143478093:TC:Tdonor_gain0.6800
7:143478097:G:GGdonor_gain0.6700
7:143477917:GC:Gdonor_gain0.6600
7:143477918:C:CGdonor_gain0.6600
7:143478094:CG:Cdonor_gain0.6600
7:143478096:A:AGdonor_gain0.6500
7:143478571:G:GTdonor_gain0.6400
7:143478462:T:TAacceptor_gain0.6300
7:143477994:T:TAdonor_gain0.6100
7:143478654:A:AGacceptor_gain0.6100
7:143478655:G:GGacceptor_gain0.6100
7:143478655:GAAC:Gacceptor_gain0.6100
7:143477963:C:CGdonor_gain0.6000
7:143478105:G:GTdonor_gain0.5900
7:143478655:GAA:Gacceptor_gain0.5900
7:143478651:T:Gacceptor_gain0.5700
7:143478654:A:Gacceptor_loss0.5700
7:143478655:G:Aacceptor_loss0.5700
7:143478637:A:AGacceptor_gain0.5600
7:143478638:A:Gacceptor_gain0.5500
7:143477996:C:Gdonor_gain0.5400
7:143478089:A:Tdonor_gain0.5400
7:143478615:T:Aacceptor_gain0.5400
7:143478398:A:Tdonor_gain0.5300
7:143478493:G:GCacceptor_gain0.5300

AlphaMissense

2008 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:143478182:A:CS104R0.946
7:143478184:T:AS104R0.946
7:143478184:T:GS104R0.946
7:143478173:A:CS101R0.935
7:143478175:C:AS101R0.935
7:143478175:C:GS101R0.935
7:143478458:T:CF196L0.925
7:143478460:T:AF196L0.925
7:143478460:T:GF196L0.925
7:143478020:A:CS50R0.923
7:143478022:C:AS50R0.923
7:143478022:C:GS50R0.923
7:143478191:T:CF107L0.908
7:143478193:C:AF107L0.908
7:143478193:C:GF107L0.908
7:143477944:T:AN24K0.892
7:143477944:T:GN24K0.892
7:143478587:T:CF239L0.887
7:143478589:C:AF239L0.887
7:143478589:C:GF239L0.887
7:143478227:T:CF119L0.885
7:143478229:C:AF119L0.885
7:143478229:C:GF119L0.885
7:143477948:T:CF26L0.872
7:143477950:C:AF26L0.872
7:143477950:C:GF26L0.872
7:143477946:G:AG25D0.863
7:143478241:G:CK123N0.857
7:143478241:G:TK123N0.857
7:143478164:T:AW98R0.855

dbSNP variants (sampled 300 via entrez): RS1001055206 (7:143477168 C>A), RS1001105841 (7:143477481 C>T), RS1001671491 (7:143477434 G>A), RS1001805417 (7:143477784 T>C), RS1002137754 (7:143475910 C>T), RS1002802221 (7:143479204 G>A), RS1003851920 (7:143476548 G>GA), RS1005528657 (7:143478210 A>G), RS1009605658 (7:143479132 C>T), RS1010040085 (7:143479041 A>G), RS1010353813 (7:143477696 G>A,C), RS1011891812 (7:143478859 C>A,T), RS1013077303 (7:143479230 T>A,C), RS1013851783 (7:143476046 G>C), RS1014296729 (7:143475890 A>G)

Disease associations

OMIM: gene MIM:613965 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL3309108 (SINGLE PROTEIN)

Molecules with ChEMBL bioactivity

1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 40,234 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).

MoleculeNamePhasePatents
CHEMBL434ISOPROTERENOL440,234

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: gpcr — Taste 2 receptors

ChEMBL bioactivities

1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
8.31EC504.9nMISOPROTERENOL

CTD chemical–gene interactions

4 total (human), top 4 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases methylation1
Leaddecreases expression1
Asbestos, Crocidoliteaffects expression1
Copper Sulfateincreases expression1

ChEMBL screening assays

54 unique, capped per target: 53 functional, 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL3361957BindingAgonist activity at human TAS2R41 expressed in U2OS cells by Ga16gust44 Clone 7A FLIPR/summary (Abse5) assayIdentification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120). — Bioorg Med Chem Lett
CHEMBL4346435FunctionalAntagonist activity at recombinant human TAS2R41 transiently expressed in HEK293T co-expressing Galpha16gust44 assessed as inhibition of picric acid-induced intracellular calcium level by measuring remaining activity at 25 uM by fluo-4AM dyDiscovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists. — J Med Chem

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.